DXB vs HIQ

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

DXB

DIMERIX FPO [DXB]

37LOW

HIQ

HITIQLTD FPO [HIQ]

37LOW

Score Breakdown

DXB HIQ
Technical
51
49
Catalyst
58
47
Sentiment
50
50
Fundamental
82
54
Momentum
39
42
Risk Gate
50
21

Key Metrics

DXB Metric HIQ
$198.1MMarket Cap$7.6M
1.2MAvg Volume (20d)393K
+0.1%Short InterestN/A
$0.78552-Week High$0.040
$0.31052-Week Low$0.011
+1.6%Daily Change+33.3%
$0.325Entry Price$0.016
-594.5%ROEN/A
-219.9%Profit MarginN/A

Active Signals

DXB Signals

RSI drifting toward oversold territory — worth watching
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Strong revenue growth (+636%)
EPS estimates revised upward (+10pts)
Near 52-week low (4% of range)

HIQ Signals

Volume surging at 6.8x normal while price climbs — real buying conviction behind this move
Volume-price trend suggests distribution — sellers may be sneaking out while price holds
Volatility is expanding fast — choppy price action, so buckle up
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (0.3 quarters)
Low P/S ratio (3.8x)
Piotroski F-Score weak (1/9, low-confidence approx)
Near 52-week low (3% of range)

Ask Scout AI to compare DXB and HIQ in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
DXB Full Analysis → HIQ Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).